Treatment of chronic hepatitis C by interferon for longer duration than six months

Digestive Diseases and Sciences

Volumn 41, Issue 12 SUPPL., 1996, Pages

  Poynard, Thierry ^a   Leroy, Vincent ^b   Mathurin, Philippe ^b   Cohard, Marielle ^b   Opolon, Pierre ^b   Zarski, Jean Pierre ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NONE

Author keywords

hepatitis C virus infection; long term interferon therapy; meta analysis

Indexed keywords

ALPHA2B INTERFERON; PLACEBO;

CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; HEPATITIS C; HISTOLOGY; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; META ANALYSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030477722     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02087883     Document Type: Conference Paper

References (9)

1. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemonnier C, Trepo C, Couzigou P, Payeu JL, Sajus M, Costa JM, Vidaud M, Chaput JC and the Multicenter Study Group: A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 332:1457-1462, 1995
2. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JP: Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C. Effects of dose and duration. Hepatology 24:778-789, 1996
3. Peto R, Collins R, Gray R: Large-scale randomized evidence: large, simple trials and overviews of trials. J Clin Epidemiol 48:23-40, 1991
4. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986
5. Chemello L, Bonetti P, Cavalletto L, Talato F, Donadon V, Casarin P, Belussi F, Frezza M, Noventa F, Pontisso P, Benvegnù L, Casarin C, Alberti A, and the TriVeneto Viral Hepatitis Group: Randomized trial comparing three different regimens of alpha-2a interferon in chronic hepatitis C. Hepatology 22:700-706, 1995
6. Kasahara A, Hayashi N, Hiramatsu N, Oshita M, Hagiwara H, Katayama K, Kato M, Masazawa M, Yoshihara H, Kishida Y, Shimizu Y, Inoue A, Fusamoto H, Kamada T: Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial. Hepatology 21:291-297, 1995
7. Jouët P, Roudot-Thoraval F, Dhumeaux D, Métreau J-M, and le groupe français pour l'étude du traitement des hépatites chroniques NANB/C: Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Gastroenterology 106:686-690, 1994
8. 2b. Hepatology 18:1300-1305, 1993
9. Lin R, Roach E, Zimmerman M, Strasser S, Farrell GC, for the Australian Hepatitis C Study Group: Interferon alfa-2b for chronic hepatitis C: Effects of dose increment and duration of treatment on response rates. Results of the first multicentre Australian trial. J Hepatol 23:487-496, 1995